Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2
INCHEON, South Korea–(BUSINESS WIRE)– – Completing clinical trials for the patient convenience-enhanced ‘Remsima SC’, the subcutaneous version of Remsima®, to file a Marketing Authorization Application...